Calciphylaxis: A review

Journal of the American College of Certified Wound Specialists

Volumn 2, Issue 4, 2010, Pages 66-72

  Magro, Cynthia M ^a   Simman, Richard ^b   Jackson, Sarah ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c KETTERING MEDICAL CENTER   (United States)

Author keywords

Calciphylaxis; Calcium deposition; Microangiopathy; Skin necrosis

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; OSTEOPONTIN; PHOSPHATE; PHOSPHATE BINDING AGENT; PROTEIN C; PROTEIN S; SODIUM THIOSULFATE; VITAMIN D DERIVATIVE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ANTIOXIDANT ACTIVITY; CALCINOSIS; CLINICAL FEATURE; DIET RESTRICTION; DIET THERAPY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; HYPERCOAGULABILITY; HYPERPARATHYROIDISM; INFECTION; IRON THERAPY; MICROANGIOPATHY; PARATHYROIDECTOMY; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; SKIN NECROSIS; SMOOTH MUSCLE FIBER; TISSUE STRUCTURE; WOUND CARE;

EID: 79955599953     PISSN: 18764983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcws.2011.03.001     Document Type: Review

References (51)

1. Seyle H: Calciphylaxis. Allerg Asthma. 1961;7:241-249.
2. Rees JK, Coles GA: Calciphylaxis in man. Br Med J. 1969;2(5658): 670-672.
3. Richens G, Piepkorn MW, Krueger GG. Calcifying panniculitis associated with renal failure: a case of Selye's calciphylaxis in man. J Am Acad Dermatol. 1982l;6(4 Pt 1):537-539.
4. Wilmer WA, Magro CM: Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial. 2002;15(3):172-186.
5. Bhambri A, Del Rosso JQ: Calciphylaxis: a review. J Clin Aesthetic Dermatol. 2008;1(2):38-41.
6. Weenig RH: Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol. 2008;58(3):458-471.
7. Arseculeratne G, Evans AT, Morley SM: Calciphylaxis-a topical overview. J Eur Acad Dermatol Venereol. 2006;20(5):493-502.
8. Rogers NM, Coates PT: Calcific uraemic arteriolopathy: an update. Curr Opin Nephrol Hypertens. 2008;17(6):629-634.
9. Dwyer KM, Francis DM, Hill PA, Murphy BF: Calcific uraemic arteriolopathy: local treatment and hyperbaric oxygen therapy. Nephrol Dial Transplant. 2002;17(6):1148-1149.
10. Kolli S, Douglas J, Doumit E, Guglin M: Cardiomyopathy and calciphylaxis in a patient with normal renal function: a case report. Congest Heart Fail. 2010;16(2):71-72.
11. Almafragi A, Vandorpe J, Dujardin K: Calciphylaxis in a cardiac patient without renal disease. Acta Cardiol. 2009;64(1):91-93.
12. Hineno A, Kinoshita T, Kinoshita M, et al: Calciphylaxis as a catastrophic complication in a patient with POEMS syndrome. Case Rep Neurol. 2009;1(1):47-53.
13. Couto FM, Chen H, Blank RD, Drezner MK: Calciphylaxis in the absence of end-stage renal disease. Endocr Pract. 2006;12(4):406-410.
14. De Roma I, Filotico R, Cea M, Procaccio P, Perosa F: Calciphylaxis in a patient with POEMS syndrome without renal failure and/or hyperparathyroidism: a case report. Ann Ital Med Int. 2004;19(4):283-287.
15. Korkmaz C, D€undar E, Zubaroǧlu I: Calciphylaxis in a patient with rheumatoid arthritis without renal failure and hyperparathyroidism: the possible role of long-term steroid use and protein S deficiency. Clin Rheumatol. 2002;21(1):66-69.
16. Pollock B, Cunliffe WJ, Merchant WJ: Calciphylaxis in the absence of renal failure. Clin Exp Dermatol. 2000;25(5):389-392.
17. Barri YM, Graves GS, Knochel JP: Calciphylaxis in a patient with Crohn's disease in the absence of end-stage renal disease. Am J Kidney Dis. 1997;29(5):773-776.
18. Fader DJ, Kang S: Calciphylaxis without renal failure. Arch Dermatol. 1996;132(7):837-838.
19. Kolli S, Douglas J, Doumit E, Guglin M: Cardiomyopathy and calciphylaxis in a patient with normal renal function: a case report. Congest Heart Fail.. 2010;16(2):71-72.
20. Almafragi A, Vandorpe J, Dujardin K: Calciphylaxis in a cardiac patient without renal disease. Acta Cardiol. 2009;64(1):91-93.
21. Naik BJ, Lynch DJ, Slavcheva EG, Beissner RS: Calciphylaxis: medical and surgical management of chronic extensive wounds in a renal dialysis population. Plast Reconstr Surg. 2004;113(1):304-312.
22. Bleyer AJ, Choi M, Igwemezie B, de la Torre E, White WL: A case control study of proximal calciphylaxis. Am J Kidney Dis. 1998; 32(3):376-381.
23. Sandhu G, Gini MB, Ranade A, Djebali D, Smith S: Penile calciphylaxis: a life-threatening condition successfully treated with sodium thiosulfate. Am J Ther. 2010. Jul 10.
24. Ruggian JC, Maesaka JK, Fishbane S: Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients. Am J Kidney Dis. 1996;28(3):409-414.
25. Agarwal MM, Singh SK, Mandal AK: Penile gangrene in diabetes mellitus with renal failure: a poor prognostic sign of systemic vascular calciphylaxis. Indian J Urol. 2007;23(2):208-210.
26. Milas M, Bush RL, Lin P, et al: Calciphylaxis and non-healing wounds: the role of the vascular surgeon in a multidisciplinary treatment. J Vasc Surg. 2003;37(3):501-507.
27. Tom CW, Talreja DR: Heart of stone. Mayo Clin Proc.. 2006;81(3):335.
28. Suryadevara M, Schurman SJ, Landas SK, et al: Systemic calciphylaxis. Pediatr Blood Cancer. 2008;51(4):548-550.
29. Li YJ, Tian YC, Chen YC, et al: Fulminant pulmonary calciphylaxis and metastatic calcification causing acute respiratory failure in a uremic patient. Am J Kidney Dis. 2006;47(4):e47-53.
30. Rivera-Nieves J, Bamias G, Alfert J, Bickston SJ, Moskaluk CA, Cominelli F: Intestinal ischemia and peripheral gangrene in a patient with chronic renal failure. Gastroenterology. 2002;122(2):495-499.
31. Katsamakis G, Lukovits TG, Gorelick PB: Calcific cerebral embolism in systemic calciphylaxis. Neurology. 1998;51(1):295-297.
32. Maeda K: Systemic calciphylaxis. Intern Med. 1995;34(9):822-823.
33. Lowry LR, Tschen JA, Wolf JE, Yen A: Calcifying panniculitis and systemic calciphylaxis in an end-stage renal patient. Cutis. 1993;51(4):245-247.
34. Essary LR, Wick MR: Cutaneous calciphylaxis: an underrecognized clinicopathologic entity. Am J Clin Pathol. 2000;113(2):280-287.
35. Prinz Vavricka BM, Barry C, Victor T, Guitart J: Diffuse dermal angiomatosis associated with calciphylaxis. Am J Dermatopathol. 2009; 31(7):653-657.
36. Lachman AS, Spray TL, Kerwin DM, Shugoll GI, Roberts WC: Medial calcinosis of M€onckeberg: a review of the problem and a description of a patient with involvement of peripheral, visceral and coronary arteries. Am J Med. 1977;63(4):615-622.
37. Harris RJ, Cropley TG: Possible role of hypercoagulability in calciphylaxis: review of the literature. J Am Acad Dermatol. 2011;64(2): 405-412.
38. Mazhar AR, Johnson RJ, Gillen D, et al: Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int. 2001;60(1):324-332.
39. Chen NX, O'Neill KD, Duan D, Moe SM: Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002;62(5):1724-1731.
40. Ahmed S, O'Neill KD, Hood AF, Evan AP, Moe SM: Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis. 2001;37(6): 1267-1276.
41. Vaskuring V, Vaskuring J: The development of the pathophysiological concept of calciphylaxis in experiment and clinic. Pathophysiology. 2001;7(4):231-244.
42. Tanaka Y, Abe M, Hiasa M, et al: Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin. Clin Cancer Res. 2007;13(3):816-823.
43. Robbiani DF, Colon K, Ely S, Ely S, Chesi M, Bergsagel PL: Osteopontin dysregulation and lytic bone lesions in multiple myeloma. Hematol Oncol. 2007;25(1):16-20.
44. Colla S, Morandi F, Lazzaretti M, et al: Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia. 2005;19(12):2166-2176.
45. Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R: Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol. 2005;4(1):4.
46. Girotto JA, Harmon JW, Ratner LE, Nicol TL, Wong L, Chen H: Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Surgery. 2001;130(4):645-650. discussion 650-651.
47. Alikadic N, Kovac D, Krasna M, et al: Review of calciphylaxis and treatment of a severe case after kidney transplantation with iloprost in combination with hyperbaric oxygen and cultured autologous fibrin-based skin substitutes. Clin Transplant. 2009;23(6):968-974.
48. Arch-Ferrer JE, Beenken SW, Rue LW, Bland KI, Diethelm AG: Therapy for calciphylaxis, an outcome analysis. Surgery. 2003; 134(6):941-944. discussion 944-945.
49. Cicone JS, Petronis JB, Embert CD, Spector DA: Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis. 2004;43(6):1104-1108.
50. Fischer AH, Morris DJ: Pathogenesis of calciphylaxis: study of three cases with literature review. Hum Pathol. 1995;26(10): 1055-1064.
51. Lal G, Nowell AG, Liao J, Sugg SL, Weigel RJ, Howe JR: Determinants of survival in patients with calciphylaxis: a multivariate analysis. Surgery. 2009;146(6):1028-1034.